433 related articles for article (PubMed ID: 16321556)
21. Endometrial cancer within tamoxifen-related polyps in patients with breast cancer.
Tate S; Yamazawa K; Sekiya S
Acta Obstet Gynecol Scand; 2004 Aug; 83(8):769-70. PubMed ID: 15255851
[No Abstract] [Full Text] [Related]
22. Tamoxifen treatment for breast cancer and risk of endometrial cancer: a case-control study.
Swerdlow AJ; Jones ME;
J Natl Cancer Inst; 2005 Mar; 97(5):375-84. PubMed ID: 15741574
[TBL] [Abstract][Full Text] [Related]
23. Clinicopathologic review of malignant polyps in stage 1A carcinoma of the endometrium.
Farrell R; Scurry J; Otton G; Hacker NF
Gynecol Oncol; 2005 Aug; 98(2):254-62. PubMed ID: 15936803
[TBL] [Abstract][Full Text] [Related]
24. Endometrial pathology at dilatation and curettage in breast cancer patients: comparison of tamoxifen users and nonusers.
Gibson LE; Barakat RR; Venkatraman ES; Hoskins WJ
Cancer J Sci Am; 1996; 2(1):35-8. PubMed ID: 9166496
[TBL] [Abstract][Full Text] [Related]
25. Endometrial carcinoma following treatment for breast carcinoma in a Nigerian female. A case report and review of the literature.
Abudu EK; Musa O; Adefuye PO; Abdul Kareem FB; Agboola AO; Banjo AA
Niger Postgrad Med J; 2007 Dec; 14(4):355-7. PubMed ID: 18163149
[TBL] [Abstract][Full Text] [Related]
26. A retrospective study of tamoxifen and endometrial cancer in breast cancer patients.
Robinson DC; Bloss JD; Schiano MA
Gynecol Oncol; 1995 Nov; 59(2):186-90. PubMed ID: 7590470
[TBL] [Abstract][Full Text] [Related]
27. Postmenopausal status, hypertension and obesity as risk factors for malignant transformation in endometrial polyps.
Giordano G; Gnetti L; Merisio C; Melpignano M
Maturitas; 2007 Feb; 56(2):190-7. PubMed ID: 16963204
[TBL] [Abstract][Full Text] [Related]
28. [Precancerous lesion of the endometrium and endometrial morphology in patients with tamoxifen therapy].
Schmidt D; Horn LC
Zentralbl Gynakol; 2002 Jan; 124(1):3-9. PubMed ID: 11873307
[TBL] [Abstract][Full Text] [Related]
29. Overview of studies on endometrial cancer and other types of cancer in humans: perspectives of an epidemiologist.
MacMahon B
Semin Oncol; 1997 Feb; 24(1 Suppl 1):S1-122-S1-39. PubMed ID: 9045310
[TBL] [Abstract][Full Text] [Related]
30. Gynecologic tumors in tamoxifen-treated women with breast cancer.
Seoud MA; Johnson J; Weed JC
Obstet Gynecol; 1993 Aug; 82(2):165-9. PubMed ID: 8393156
[TBL] [Abstract][Full Text] [Related]
31. Postmenopausal bleeding from unusual endometrial polyps in women on chronic tamoxifen therapy.
Corley D; Rowe J; Curtis MT; Hogan WM; Noumoff JS; Livolsi VA
Obstet Gynecol; 1992 Jan; 79(1):111-6. PubMed ID: 1727568
[TBL] [Abstract][Full Text] [Related]
32. Endometrial cancer: incidence, prognostic factors, diagnosis, and treatment.
Creasman WT
Semin Oncol; 1997 Feb; 24(1 Suppl 1):S1-140-S1-50. PubMed ID: 9045311
[TBL] [Abstract][Full Text] [Related]
33. Long-term effects of the levonorgestrel-releasing intrauterine system on serum lipids and the endometrium in breast cancer patients taking tamoxifen.
Kesim MD; Aydin Y; Atis A; Mandiraci G
Climacteric; 2008 Jun; 11(3):252-7. PubMed ID: 18568790
[TBL] [Abstract][Full Text] [Related]
34. [Risk of endometrial hyperplasia and carcinoma in breast cancer patients receiving adjuvant tamoxifen].
Semiglazov VF; Maksimov SIa; Bulgatova EA; Meshkova IE; Chepik OF; Berstein LM
Vopr Onkol; 2003; 49(2):198-204. PubMed ID: 12785205
[TBL] [Abstract][Full Text] [Related]
35. Tamoxifen and malignant epithelial-nonepithelial tumours of the endometrium: report of six cases and review of the literature.
Treilleux T; Mignotte H; Clement-Chassagne C; Guastalla P; Bailly C
Eur J Surg Oncol; 1999 Oct; 25(5):477-82. PubMed ID: 10527595
[TBL] [Abstract][Full Text] [Related]
36. [Postmenopausal hemorrhage and endometrial cancer in tamoxifen therapy].
Krause A; Gerber B
Zentralbl Gynakol; 1994; 116(1):44-7. PubMed ID: 8147180
[TBL] [Abstract][Full Text] [Related]
37. A clinicopathologic study on patients with endometrial cancer after adjuvant tamoxifen treatment for breast cancer: a single center experience.
Ravazoula P; Androutsopoulos G; Zyli P; Michail G; Kardamakis DM; Kourounis G
Breast J; 2006; 12(6):578-84. PubMed ID: 17238994
[No Abstract] [Full Text] [Related]
38. [Morphologic endometrium changes with tamoxifen].
Dallenbach-Hellweg G; Hahn U; Schmidt D
Zentralbl Gynakol; 1996; 118(6):365-9. PubMed ID: 8768015
[TBL] [Abstract][Full Text] [Related]
39. Tamoxifen and the endometrium: review of 102 cases and comparison with HRT-related and non-HRT-related endometrial pathology.
Kennedy MM; Baigrie CF; Manek S
Int J Gynecol Pathol; 1999 Apr; 18(2):130-7. PubMed ID: 10202670
[TBL] [Abstract][Full Text] [Related]
40. Tamoxifen-induced endometrial polyp. A case report and review of the literature.
Nomikos IN; Elemenoglou J; Papatheophanis J
Eur J Gynaecol Oncol; 1998; 19(5):476-8. PubMed ID: 9863916
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
